Zimmer Biomet - Due diligence report

A 360° intelligence report on Zimmer Biomet: trust score, financial health, credit view, compliance, directors, growth and distress signals …

2019-12-17 Mumbai, Maharashtra Active Unlisted
Connect MCP
ZB Zimmer Biomet
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Zimmer Biomet — 360° Intelligence Report

Generated from MCA filings & public records
88/100
Trust Score
Low Risk

Zimmer Biomet is assessed as Low Risk with a Trust Score of 88/100. Zimmer Biomet is an active private limited foreign company incorporated in india incorporated in 2019, operating in the Healthcare sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 21 Sep 2026 from the latest processed filings. Zimvie India Private Limited snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
88/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
90/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 90/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
AMRUT DHANANJAY PARAB 01234567 Director 01/04/2018 6 yrs Approved
Pramod Bhutra 01234567 Director 01/04/2018 6 yrs Approved
Saurabh Singh 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Jerds Luxembourg Holding S.a.r.l
Subsidiaries
-
Group entities
-
Capital events
3 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Jerds Luxembourg Holding S.a.r.l Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 80 · Distress 90
Growth signals & trust indicators
Latest year revenue grew 1.42.
Profit expanded 2.1x year-on-year.
Net margin improved to 24%.
EPFO headcount growing - hiring signal.
Operating for 6 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence89/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment90/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view86/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 12 events
20 Oct 2025
Director appointed
Saurabh Singh (Additional Director)
08 Oct 2025
Director appointed
Pramod Bhutra (Company Secretary)
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
28 Sep 2023
Director ceased
HEATHER JANE KIDWELL
25 Feb 2022
Director ceased
WOEI CHUN YEOH
25 Mar 2021
Securities allotted
4500000 Equity Shares - 4.50 cr raised
15 Jan 2021
Director ceased
SAMIR BHATTACHARYA
24 Aug 2020
Securities allotted
10000000 Equity Shares - 10.00 cr raised
06 Mar 2020
Director ceased
RAKESH JULKA
17 Dec 2019
Incorporated
Registered with Roc Mumbai
Director appointed
AMRUT DHANANJAY PARAB (Director)
10

Key Observations

Auto-generated from the data above
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 3 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Rex Printing & Bindry Equipments Private Limited U72219DL2005PTC134987 Delhi, Delhi, India
Chemistry Design Private Limited U74110MH2014PTC253287 Thane, Maharashtra, India
Stiger Switch India Private Limited U31904DL2015PTC278979 Delhi, Delhi, India
Behr Bircher Cellpack Bbc India Private Limited U74999DL2018PTC341666 New Delhi, Delhi, India
Gyan Plantations Private Limited U01100MH1995PTC087946 Mumbai, Maharashtra, India
V K Auto Zone Private Limited U50102UP2013PTC055102 Sultanpur, Uttar Pradesh, India
Rareenterprises U74110MH1993PTC074456 Mumbai, Maharashtra, India
Mcak Herbs And Spices Private Limited U51909DL2021PTC391361 Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Zimmer Biomet before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Zimmer Biomet: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 90/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Zimmer Biomet - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 88/100, distress signals and MSME payment-delay disclosures - know whether Zimmer Biomet pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Zimmer Biomet - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Zimmer Biomet an active company?

Zimmer Biomet has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Zimmer Biomet financially healthy?

Zimmer Biomet has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Zimmer Biomet?

Its overall Trust Score is 88/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Zimmer Biomet?

The ultimate holding entity is Jerds Luxembourg Holding S.a.r.l. 3 active director(s) are on record.

Does Zimmer Biomet have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Zimmer Biomet up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Zimmer Biomet?

Its Credit Risk Score is 90/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.